Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMP2.1/AS02A Malaria Vaccine in Malian Children
NCT00460525Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- May 2007
- Primary completion
- Jul 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of FMP2.1/AS02A in Plasmodium falciparum malaria (2 arms), sponsored by U.S. Army Medical Research and Development Command. Primary endpoints: Number of Subjects Reporting Solicited Adverse Events, Number of Unsolicited Non-serious Adverse Events and 2 more. Started May 2007; status: completed.
02
Drugs
FMP2.1/AS02A
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT00460525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00460525.